I know them through the case of a very close relative whom I have accompanied in different appointments/treatments. I can only say that my family member has improved a lot with the treatments applied, to date we only do regular check-ups. The treatment by the medical team has been great and the side effects of the treatment have been very few. I would recommend that people who have an oncological problem at least arrange a visit and give you their opinion.

Magnificent attention from both the administration and healthcare staff. Very satisfied. Thank you!!!

Not responding to request

No good reaponse

Hello, I'm Gretaelin Hoffman, 76 years old, married to a younger partner, with three children and six grandchildren. In 1986, I was diagnosed with primary progressive multiple sclerosis (MS) at Rick's Hospital University Clinic in Oslo. Unfortunately, there was no treatment available at that time, and I never received any treatment for MS. Nine years ago, my condition worsened, and even the university clinic couldn't help. I joined a Facebook group for MS patients and learned about Professor Slaughter. In 2000, I sought stem cell treatment at Biotherapy International in Israel, where my own stem cells were expanded. I experienced improvements and entered full remission, lasting five years. However, in 2021, my condition deteriorated again. Before the COVID-19 pandemic, Professor Slaughter recommended placenta umbilical stem cells due to my age. In 2021, I underwent another treatment, receiving allogeneic mesenchymal stem cells. The results were positive, maintaining a good quality of life. The treatment aims to address MS on two fronts. Firstly, as MS is an autoimmune disease, it works to halt the inflammatory process and prevent attacks on the central nervous system. Secondly, laboratory evidence suggests that mesenchymal stem cells can potentially differentiate into neural cells, which may aid in remyelination, crucial in MS where inflammation leads to demyelination. The treatment involves administering chromosomal cells intravenously to regulate the immune system and intrathecally into the spinal fluid to reach the central nervous system. Additional non-invasive machines, including deep transmagnetic stimulation, low-energy acoustic shock waves, and low-energy laser-like therapy, are used to enhance the effects of the treatment.